Clinical Trial Update: An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1 [Phase 3]

View source ↗

Summary

An extension study to demonstrate long-term efficacy and safety of CT-P13 when co-administered with methotrexate in rheumatoid arthritis patients who previously…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Remsima/Inflectra (infliximab biosimilar CT-P13) (infliximab biosimilar CT-P13)

Snippet

Sponsor: Celltrion | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED